Who
Todd Harris
President and CEO
Company insider
Files Form 4 as: President and CEO, Tyra Biosciences; Head of Corporate Development, Sienna Biopharmaceuticals.
In numbers
- Trades disclosed
- 106
- Buys
- 0
- Sells
- 45
- Bought
- $0
- Sold
- $9.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 26 Jul 2017
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | $7,887864 at $9.13 | filing |
| 15 Sep 2026filed 17 Sep 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | $7,888864 at $9.13 | filing |
| 5 May 2026filed 7 May 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | —79,000 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —265,000 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —265,000 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | —79,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | $13K1,463 at $9.13 | filing |
| 13 Mar 2026filed 17 Mar 2026 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | $13K1,463 at $9.13 | filing |
| 7 Aug 2025filed 7 Aug 2025 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —570,000 at $0.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Code A | $12K1,241 at $9.78 | filing |
| 21 Oct 2024filed 22 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $161K5,896 at $27.32 | filing |
| 21 Oct 2024filed 22 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $371K13,188 at $28.16 | filing |
| 18 Oct 2024filed 22 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $1.2M43,636 at $27.01 | filing |
| 17 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $393K15,194 at $25.84 | filing |
| 17 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $5,274200 at $26.37 | filing |
| 16 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $124K4,900 at $25.22 | filing |
| 16 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $642K24,475 at $26.23 | filing |
| 16 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $106K3,922 at $26.98 | filing |
| 15 Oct 2024filed 17 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $244K10,035 at $24.31 | filing |
| 30 Sep 2024filed 2 Oct 2024 | TYRA Tyra BiosciencesBiotechnology | SEC FORM 4 Sold | $12K500 at $24.00 | filing |
News
Tyra Biosciences (NASDAQ:TYRA) Stock Jumps 4.4% – Here's WhyTYRA · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Todd Harris; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.